NEW AP116 Cytologic/FNA Evaluation of Lymphoid Proliferations: Integration of Clinical, Morphologic, Flow Cytometric, FISH, and Molecular Testing in Diagnosis and Classification
2:00–5:30 pm
3.0 CME CREDITS
Cytologic evaluation, including fine-needle aspiration (FNA), is a valuable diagnostic tool in the evaluation of lymphoproliferative disorders and is less invasive than tissue biopsy. Cytology distinguishes reactive from neoplastic conditions and in some situations allows accurate classification of lymphoproliferative disorders. Focusing on cytologic/FNA evaluation to distinguish reactive from neoplastic T- and B-cell disorders, faculty will outline situations where subclassifcation of B-cell lymphoproliferative disorders is appropriate. Learn the role of flow cytometry, FISH, and molecular testing, as well as diagnostic pitfalls and situations that require tissue biopsy for accurate diagnosis and classification.
You will learn to:
- Identify cytologic, flow cytometric, FISH, and molecular features distinguishing reactive from neoplastic T- and B-cell proliferations
- Use cytology for diagnosis and classification of lymphoproliferative disorders
- Explain flow cytometric, FISH, and molecular findings supporting diagnosis and classification of lymphoproliferative disorders
- Triage cytologic/FNA material for ancillary testing
- Recognize limitations of cytology in evaluation of lymphoid proliferations
Faculty
Anne M. Deucher, MD, PhD, FCAP
Joan E. Etzell, MD, FCAP
Stephanie J. McAlhany, MD, PhD, FCAP